| Product Code: ETC7915964 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Mononucleosis Diagnostic Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Mononucleosis Diagnostic Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Mononucleosis Diagnostic Market - Industry Life Cycle |
3.4 Latvia Mononucleosis Diagnostic Market - Porter's Five Forces |
3.5 Latvia Mononucleosis Diagnostic Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.6 Latvia Mononucleosis Diagnostic Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Latvia Mononucleosis Diagnostic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about mononucleosis and its symptoms leading to higher demand for diagnostic tests. |
4.2.2 Growing investments in healthcare infrastructure in Latvia to improve diagnostic capabilities. |
4.2.3 Rising prevalence of mononucleosis cases in the region driving the need for accurate and timely diagnostics. |
4.3 Market Restraints |
4.3.1 Limited availability of advanced diagnostic technologies for mononucleosis in Latvia. |
4.3.2 High costs associated with diagnostic tests and treatments for mononucleosis affecting market growth. |
5 Latvia Mononucleosis Diagnostic Market Trends |
6 Latvia Mononucleosis Diagnostic Market, By Types |
6.1 Latvia Mononucleosis Diagnostic Market, By Test Type |
6.1.1 Overview and Analysis |
6.1.2 Latvia Mononucleosis Diagnostic Market Revenues & Volume, By Test Type, 2021- 2031F |
6.1.3 Latvia Mononucleosis Diagnostic Market Revenues & Volume, By Epstein Barr Virus (EBV) Antibody Test, 2021- 2031F |
6.1.4 Latvia Mononucleosis Diagnostic Market Revenues & Volume, By Monospot Test, 2021- 2031F |
6.1.5 Latvia Mononucleosis Diagnostic Market Revenues & Volume, By Complete Blood Count Test, 2021- 2031F |
6.2 Latvia Mononucleosis Diagnostic Market, By End-User |
6.2.1 Overview and Analysis |
6.2.2 Latvia Mononucleosis Diagnostic Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 Latvia Mononucleosis Diagnostic Market Revenues & Volume, By Laboratories, 2021- 2031F |
6.2.4 Latvia Mononucleosis Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
7 Latvia Mononucleosis Diagnostic Market Import-Export Trade Statistics |
7.1 Latvia Mononucleosis Diagnostic Market Export to Major Countries |
7.2 Latvia Mononucleosis Diagnostic Market Imports from Major Countries |
8 Latvia Mononucleosis Diagnostic Market Key Performance Indicators |
8.1 Average turnaround time for mononucleosis diagnostic tests. |
8.2 Rate of adoption of new diagnostic technologies for mononucleosis. |
8.3 Percentage of healthcare facilities offering mononucleosis diagnostic services. |
8.4 Patient satisfaction scores related to the accuracy and speed of mononucleosis diagnostic tests. |
9 Latvia Mononucleosis Diagnostic Market - Opportunity Assessment |
9.1 Latvia Mononucleosis Diagnostic Market Opportunity Assessment, By Test Type, 2021 & 2031F |
9.2 Latvia Mononucleosis Diagnostic Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Latvia Mononucleosis Diagnostic Market - Competitive Landscape |
10.1 Latvia Mononucleosis Diagnostic Market Revenue Share, By Companies, 2024 |
10.2 Latvia Mononucleosis Diagnostic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |